Related Experiment Videos
Evaluation of serum rosette inhibitory factors in chronic liver disease
Insights
Serum rosette inhibitory factors (IF) were detected in chronic active liver disease (CALD) patients. In HBsAg negative CALD, IF may be anti-T lymphocyte antibodies, unlike in HBsAg positive cases.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Chronic active liver disease (CALD) involves persistent liver inflammation.
- Immune system dysregulation plays a role in CALD pathogenesis.
- Hepatitis B surface antigen (HBsAg) status is a key factor in liver disease management.
Purpose of the Study:
- To investigate the presence and nature of serum rosette inhibitory factors (IF) in CALD patients.
- To differentiate IF in HBsAg positive versus HBsAg negative CALD.
- To explore the potential role of IF in immune modulation within CALD.
Main Methods:
- Detection of serum IF in HBsAg positive and negative CALD patients.
- Analysis of IF in patients with and without immunosuppressive treatment.
- Gamma-globulin precipitation and supernatant analysis.
- Correlation analysis with T-cell factors (IFL), immune complexes (IC), and lymphocytotoxins.
Main Results:
- IF detected in 61% of HBsAg negative and 78% of HBsAg positive CALD patients (untreated).
- IF prevalence differed significantly in treated patients (18% HBsAg negative vs. 66% HBsAg positive).
- IF disappeared from supernatant in HBsAg negative sera after gamma-globulin precipitation, but persisted in HBsAg positive sera.
- Correlation found between IF and T-cell factors only in HBsAg negative cases; no correlation with IC or lymphocytotoxins.
Conclusions:
- Serum IF in HBsAg negative CALD are likely immunoglobulins, potentially anti-T lymphocyte antibodies.
- IF in HBsAg positive CALD appear to be distinct, at least partially.
- The findings suggest different immune mechanisms in HBsAg positive and negative CALD, influencing immune response modulation.
Abstract:
Serum rosette inhibitory factors (IF) were detected in 61% of 18 sera from HBsAg negative and in 78% of 14 sera from HBsAg positive chronic active liver disease (CALD) patients, who were not under immunosuppressive treatment. In CALD patients, who were under treatment for at least 6 months, IF were detected in 66% of the HBsAg positive patients and only in 18% of the HBsAg negative ones. After precipitation of the serum gamma-globulins by ammonium sulphate, IF were found in the supernatant only in HBsAg positive sera, while completely disappeared in HBsAg negative ones. A significant correlation between serum IF and factors reacting in immunofluorescence (IFL) with a T enriched preparation of lymphocytes was documented only in HBsAg negative cases. No correlation was found between serum IF and circulating immune complexes (IC) or lymphocytotoxins in any of the sera tested. From all these data it is concluded that serum IF detectable in HBsAg negative CALD cases are probably immunoglobulins. Our data would favour the hypothesis that they are anti-T lymphocytes antibodies, since no correlation was found between serum IF and circulating IC. Similar factors, detectable in HBsAg positive sera, are, at least in part, different. The role of such factors in the modulation of the immune response in CALD patients is discussed.